HZHimesh B. Zaver

Himesh B. Zaver

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Himesh B. Zaver has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bite-on-Bite Near Miss: From Hemangioma to Gastrointestinal Stromal Tumors

    by Olivia Reszczynski, Himesh B. Zaver, Dev Patel, Christopher Farid, Steven Powell, Daniel S. Strand

    Gastrointestinal stromal tumors (GISTs) are rare, potentially malignant mesenchymal neoplasms that can arise anywhere within the gastrointestinal tract or abdominal cavity. We present a case of an incidentally discovered duodenal subepithelial lesion that was initially endoscopically sampled using bite-on-bite biopsy technique and misdiagnosed as a benign hemangioma. Following multidisciplinary review, the patient underwent endoscopic ultrasound with fine-needle aspiration and fine-needle biopsy, which ultimately confirmed the diagnosis of GIST. This case highlights the limitations of the bite-on-bite technique for diagnosing subepithelial lesions and underscores the importance of multidisciplinary evaluation when managing potentially high-risk subepithelial lesions.

  • Open Access

    Predictors of Missed Appointments in Digestive Health: A Comparative Analysis of Telehealth and In-Person Visits

    by Himesh B. Zaver, Olivia Reszczynski, Aditya Singh, Tsola Efejuku, Robert Cutler, Alexander Podboy

    INTRODUCTION: Telehealth access is integral to digestive health care. This study examined demographic, insurance, and social determinants of health associated with missed telehealth appointments, with secondary comparisons with missed in-person visits. METHODS: A single-center cohort study of adult digestive health patients at the University of Virginia (2019–2024) was conducted. A total of 2,047 encounters were analyzed, including 1,356 telehealth visits (662 no-shows, 694 completed visits) and 691 in-person no-shows. Patient-level data were obtained from the electronic health record, and county-level broadband and socioeconomic data were derived from the Federal Communications Commission's Mapping Broadband Health in America platform. Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) for factors associated with nonattendance. RESULTS: Younger age (aOR 0.97 per year increase, 95% CI 0.93–0.98), Black race (aOR 1.46, 95% CI 1.02–2.19), and Hispanic/Latino ethnicity (aOR 2.32, 95% CI 1.14–6.20) were independently associated with telehealth nonattendance, whereas Medicare coverage was associated with lower odds of missed telehealth visits (aOR 0.84, 95% CI 0.26–0.88). Patients new to the tertiary care center and those presenting for an initial subspecialty visit had higher odds of telehealth nonattendance. Nonattendance varied by clinic section, with higher odds observed in Fellow's, inflammatory bowel disease, and nutrition clinics and lower odds in hepatology and transplant clinics. In secondary analyses comparing telehealth and in-person no-shows, Black patients had lower odds of telehealth nonattendance relative to in-person nonattendance (aOR 0.61, 95% CI 0.44–0.84). County-level broadband access and socioeconomic measures did not differ significantly between cohorts. DISCUSSION: Disparities in digestive health appointment attendance persist across both telehealth and in-person care. Telehealth nonattendance was associated with patient demographic and health system factors, suggesting that telehealth expansion alone may not eliminate disparities in healthcare delivery. These findings highlight the importance of patient-level interventions and stable telehealth policies to support equitable access to digestive health care.


  • Open Access

    A Post-transplant Immunosuppression Complication: Epstein-Barr Virus-Positive Classic Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder

    by Himesh B. Zaver, Gautham Prakash, Samuel Plant, Jigisha Chaudhari, Jason Erno, Ayman Mithqal, Elizabeth Courville, Enrica Marchi, Zachary Henry

    Post-transplant lymphoproliferative disorder (PTLD) is a potential life-threatening complication after solid organ transplantation. PTLD can be associated with Epstein-Barr virus through either primary infection or reactivation during treatment with immunosuppressive medications. We present a rare case of Epstein-Barr virus-positive classical Hodgkin lymphoma PTLD following liver transplantation, which was initially misattributed to late transplant rejection and raised concerns for cholangiocarcinoma due to abnormal laboratory and imaging findings.


  • Open Access

    Pilot Study: Personalized Medicine in Endoscopy, Can Pharmacogenomics Predict Response to Conscious Sedation?

    by Himesh B. Zaver, Hassan Ghoz, Balkishan Malviya, Aman Bali, Samuel Antwi, Ann M. Moyer, Yan Bi

    Background: Adequate response to moderate (conscious) sedation varies significantly between individuals. Polymorphisms in genes encoding drug metabolizing enzymes can lead to inter-individual variability in drug efficacy, potentially influencing sedation requirements during endoscopic procedures. Objectives: The aim of this study was to assess the potential role of inter-individual variation in inherited polymorphisms of drug-metabolizing enzymes, cytochrome P450 (CYP450), specifically CYP3A4 and CYP3A5, in sedation requirements for outpatient endoscopic procedures. Methods: A retrospective analysis of sedation requirements and pharmacogenomics data in 106 unique patients who received outpatient esophagogastroduodenoscopy (EGD), colonoscopy, or both between December 2011 and February 2019 was conducted. Patients were divided into two groups based on their sedation requirements during endoscopy (high vs. normal sedation). Results: Patients with reduced a CYP2C19 metabolism (poor + intermediate metabolizers) (odds ratio [OR] = 0.38, 95% confidence interval [CI]: 0.16–0.91, p = 0.03), poor CYP3A5 metabolism (OR = 0.25, 95% CI: 0.095–0.65, p = 0.0046), and poor UGT1A1 (OR = 2.76, 95% CI: 1.07–7.13, p = 0.08) had higher odds of requiring normal sedation compared to those with CYP2C19 increased metabolism, CYP3A5 intermediate metabolism, and UGT1A1 intermediate metabolism. Conclusion: Information about inter-individual variation in (CYP450) genes may be useful for determining the sedation requirements for outpatient endoscopic procedures. We found that patients with reduced CYP2C19 metabolism, poor CYP3A5 metabolism, and poor UGT1A1 metabolism were more likely to require normal sedation requirements during outpatient endoscopic procedures.

  • Open Access

    Severe Mpox Proctitis Complicated by Bowel Obstruction

    by Hasan Saleh, Bao T. Ho, Justin T. Call, Marie M. Plante, Himesh B. Zaver, Harry R. Powers, Allie M. Metcalfe, Charles G. Graham, Michele D. Lewis

    Mpox is a rare infection caused by the zoonotic orthopoxvirus. We present the case of a 44-year-old man with HIV and a history of kidney transplant who presented with mpox and developed proctitis-associated bowel obstruction, urinary retention, and eosinophilia. Our case highlights potential gastrointestinal manifestations of severe mpox infection.


  • Utility of an Artificial Intelligence Enabled Electrocardiogram for Risk Assessment in Liver Transplant Candidates

    by Himesh B. Zaver, Obaie Mzaik, Jonathan Thomas, Joanna Roopkumar, Demilade Adedinsewo, Andrew P. Keaveny, Tushar Patel

    Background Post-operative cardiac complications occur infrequently but contribute to mortality after liver transplantation (LT). Artificial intelligence-based algorithms based on electrocardiogram (AI-ECG) are attractive for use during pre-operative evaluation to screen for risk of post-operative cardiac complications, but their use for this purpose is unknown. Aims The aim of this study was to evaluate the performance of an AI-ECG algorithm in predicting cardiac factors such as asymptomatic left ventricular systolic dysfunction or potential for developing post-operative atrial fibrillation (AF) in cohorts of patients with end-stage liver disease either undergoing evaluation for transplant or receiving a liver transplant. Methods A retrospective study was performed in two consecutive adult cohorts of patients who were either evaluated for LT or underwent LT at a single center between 2017 and 2019. ECG were analyzed using an AI-ECG trained to recognize patterns from a standard 12-lead ECG which could identify the presence of left ventricular systolic dysfunction (LVEF < 50%) or subsequent atrial fibrillation. Results The performance of AI-ECG in patients undergoing LT evaluation is similar to that in a general population but was lower in the presence of prolonged QTc. AI-ECG analysis on ECG in sinus rhythm had an AUROC of 0.69 for prediction of de novo post-transplant AF. Although post-transplant cardiac dysfunction occurred in only 2.3% of patients in the study cohorts, AI-ECG had an AUROC of 0.69 for prediction of subsequent low left ventricular ejection fraction. Conclusions A positive screen for low EF or AF on AI-ECG can alert to risk of post-operative cardiac dysfunction or predict new onset atrial fibrillation after LT. The use of an AI-ECG can be a useful adjunct in persons undergoing transplant evaluation that can be readily implemented in clinical practice. Graphical Abstract


  • Open Access

    Reduction in Health Care Facility–Onset Clostridioides difficile Infection: A Quality Improvement Initiative

    by Himesh B. Zaver, Varun P. Moktan, Eugene P. Harper, Aman Bali, Ayan Nasir, Carla Foulks, Justin Kuhlman, Max Green, Gillian A. Algan, Heather C. Parth, et al.